Chemed (Chemed) Additional Paid-In Capital : $1,341 Mil(As of Dec. 2023)

View and export this data going back to 1982. Start your Free Trial

What is Chemed Additional Paid-In Capital?

Chemed's quarterly additional paid-in capital increased from Jun. 2023 ($1,240 Mil) to Sep. 2023 ($1,254 Mil) and increased from Sep. 2023 ($1,254 Mil) to Dec. 2023 ($1,341 Mil).

Chemed's annual additional paid-in capital increased from Dec. 2021 ($1,044 Mil) to Dec. 2022 ($1,150 Mil) and increased from Dec. 2022 ($1,150 Mil) to Dec. 2023 ($1,341 Mil).

Chemed Additional Paid-In Capital Historical Data

The historical data trend for Chemed's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemed Additional Paid-In Capital Chart

Chemed Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

860.67

961.40

1,044.34

1,149.90

1,341.27

Chemed Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															1,149.90	1,186.12	1,240.42	1,254.36	1,341.27

Chemed Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Chemed Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Chemed's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Chemed (Chemed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Chemed Corp (NYSE:CHE) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

CXM:Germany

Address

255 East Fifth Street, Suite 2600, Cincinnati, OH, USA, 45202-4726

Website

https://www.chemed.com

Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative-care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. Chemed generates the majority of its revenue from business in the United States.

Executives

Kevin J Mcnamara	director, officer: president & ceo	2500 CHEMED CENTER, 255 EAST FIFTH ST, CINCINNATI OH 45202
Spencer S Lee	officer: vice president	2500 CHEMED CENTER, 255 EAST FIFTH ST, CINCINNATI OH 45202
David Patrick Williams	officer: Vice President & CFO
Nicholas Michael Westfall	officer: Executive Vice President	8035 PEREGRINE LANE, CINCINNATI OH 45243
Patrick P Grace	director	1100 PARK AVE, APT 15C, NEW YORK NY 10128
Eileen P Mccarthy	director	3515 78TH STREET, #2, JACKSON HEIGHTS NY 11372
Michael D Witzeman	officer: vice president and controller	255 E 5TH STREET, SUITE 2600, CINCINNATI OH 45202
Mount John Meredith Jr.	director	2906 MABRY ROAD NE, ATLANTA GA 30319
Donald E Saunders	director	306 MIANI TRAIL, OXFORD OH 45056
Christopher J Heaney	director	101 S. FORT LAUDERDALE BEACH BLVD., APARTMENT 1602, FORT LAUDERDALE FL 33316
Ron Delyons	director	2692 MADISON ROAD, SUITE N1-313, CINCINNATI OH 45208
Naomi C Dallob	officer: VP and Chief Legal Officer	255 EAST FIFTH STREET, SUITE 2600, CINCINNATI OH 45202
Thomas C Hutton	director, officer: vice president	ONE ROCKEFELLER PLAZA, STE 1510, NEW YORK NY 10020
Walsh George J Iii	director	ONE CHASE MANHATTAN PLAZA, NEW YORK NY 10005
Andrea R Lindell	director